US Patent 9358278 Capsular polysaccharide solubilisation and combination vaccines
Patent 9358278 was granted and assigned to Novartis on June, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 20, 2009
Date of Patent
June 7, 2016
Patent Application Number
12321464
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9358278 Capsular polysaccharide solubilisation and combination vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
